Zobrazeno 1 - 10
of 214
pro vyhledávání: '"Sue Ann Costa"'
Autor:
Wonyeong Jung, Dansu Yuan, Benjamin Kellman, Isabela Garrido da Silva Gonzalez, Ralf Clemens, Eveline Pipolo Milan, Eduardo Sprinz, José Cerbino Neto, Igor Smolenov, Galit Alter, Ryan P. McNamara, Sue Ann Costa Clemens
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-10 (2024)
Abstract With the continued emergence of variants of concern, the global threat of COVID-19 persists, particularly in low- and middle-income countries with limited vaccine access. Protein-based vaccines, such as SCB-2019, can be produced on a large s
Externí odkaz:
https://doaj.org/article/718ae9b1dfb44fbcb54c0861cbdcc9e0
Publikováno v:
Frontiers in Public Health, Vol 12 (2024)
BackgroundLatin America (Latam) has a tradition of large-scale vaccine trials. Because of fluctuating demand, many sites have downsized their infrastructure. Therefore, BMGF launched a clinical trial site-readiness initiative early in the coronavirus
Externí odkaz:
https://doaj.org/article/55572526f56a4ebd8c2622f3f426851c
Autor:
Yauba Saidu, Jessica Gu, Budzi Michael Ngenge, Sangwe Clovis Nchinjoh, Amani Adidja, Nadege Edwidge Nnang, Nkwain Jude Muteh, Vouking Marius Zambou, Clarence Mvalo Mbanga, Valirie Ndip Agbor, Diaby Ousmane, Andreas Ateke Njoh, Junie Flegere, Demba Diack, Owens Wiwa, Emanuele Montomoli, Sue Ann Costa Clemens, Ralf Clemens
Publikováno v:
Human Resources for Health, Vol 21, Iss 1, Pp 1-9 (2023)
Abstract Background Immunization is regarded as one of the most cost-effective public health interventions in global health. However, its cost-effectiveness depends greatly on the knowledge and skills of vaccinators. With the growing complexity of im
Externí odkaz:
https://doaj.org/article/24b8670237394b32a7b8be9189ba5492
Publikováno v:
Vaccines, Vol 12, Iss 8, p 826 (2024)
A strategic priority of the World Health Organization’s Immunization Agenda 2030 is to increase vaccination coverage and equity through reaching “zero-dose” children. Through an ecological study, we sought to quantify the impact of the COVID-19
Externí odkaz:
https://doaj.org/article/3863f398f7614fda91e4b5656868302b
Autor:
Yauba Saidu, Jessica Gu, Budzi Michael Ngenge, Sangwe Clovis Nchinjoh, Amani Adidja, Nadege Edwidge Nnang, Nkwain Jude Muteh, Vouking Marius Zambou, Clarence Mbanga, Valirie Ndip Agbor, Diaby Ousmane, Andreas Ateke Njoh, Junie Flegere, Demba Diack, Owens Wiwa, Emmanuele Montomoli, Sue Ann Costa Clemens, Ralf Clemens
Publikováno v:
BMC Health Services Research, Vol 23, Iss 1, Pp 1-8 (2023)
Abstract Background One crucial obstacle to attaining universal immunization coverage in Sub-Saharan Africa is the paucity of timely and high-quality data. This challenge, in part, stems from the fact that many frontline immunization staff in this pa
Externí odkaz:
https://doaj.org/article/85c86611ff5d4c52ba5b4c51aa97653b
Publikováno v:
Revista Panamericana de Salud Pública, Vol 47, Iss 99, Pp 1-5 (2023)
Poliovirus infection causes paralysis in up to 1 in 200 infected persons. The use of safe and effective inactivated poliovirus vaccines and live attenuated oral poliovirus vaccines (OPVs) means that only two pockets of wildtype poliovirus type 1 rema
Externí odkaz:
https://doaj.org/article/0004bde4e9584429bfacac1c406e1b27
Autor:
Sue Ann Costa Clemens, Natalie Marchevsky, Sarah Kelly, Sally Felle, Ahmed Eldawi, Rupetha Rajasingam, Rawan Mahmud, Teresa Lambe, Merryn Voysey, Isabela Gonzalez, Eveline Pipolo Milan, Maria Cleonice Justino, Sagida Bibi, Parvinder Aley, Ralf Clemens, Andrew J. Pollard
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 2 (2023)
In this phase 4 study we assessed boosting with fractional doses of heterologous COVID-19 vaccines in Brazilian adults primed with two doses of CoronaVac (Sinovac/Butantan, São Paulo, Brazil) at least 4 months previously. Participants received eithe
Externí odkaz:
https://doaj.org/article/6010a5ea087349dfbb0a8d6440fc71e3
Autor:
Feyrouz Damji Kurji, Ananda Sankar Bandyopadhyay, Simona Zipursky, Laura V. Cooper, Chris Gast, Margaret Toher, Ralf Clemens, Sue Ann Costa Clemens, Rayasam Prasad, Adriansjah Azhari
Publikováno v:
Pathogens, Vol 13, Iss 4, p 273 (2024)
A sharp rise in circulating vaccine-derived poliovirus type 2 (cVDPV2) outbreaks in the years following the cessation of routine use of poliovirus type 2-containing oral polio vaccine and the trend of seeding new emergences with suboptimal vaccinatio
Externí odkaz:
https://doaj.org/article/230f5ebb3eff4457a7ea10944e85c332
Autor:
Sue Ann Costa Clemens, Ralf Clemens
Publikováno v:
Jornal de Pediatria, Vol 99, Iss , Pp S37-S45 (2023)
Objective: To identify and describe learnings from past pandemics and to suggest a framework for vaccine development as part of epi/pandemic readiness. Source of data: Articles/ reviews/letters on pandemic preparedness/ vaccines published between 200
Externí odkaz:
https://doaj.org/article/f700b93d3cfe41ea97bb4fe1be34f427
Autor:
Sue Ann Costa Clemens, Pedro M. Folegatti, Katherine R. W. Emary, Lily Yin Weckx, Jeremy Ratcliff, Sagida Bibi, Ana Verena De Almeida Mendes, Eveline Pipolo Milan, Ana Pittella, Alexandre V. Schwarzbold, Eduardo Sprinz, Parvinder K. Aley, David Bonsall, Christophe Fraser, Michelle Fuskova, Sarah C. Gilbert, Daniel Jenkin, Sarah Kelly, Simon Kerridge, Teresa Lambe, Natalie G. Marchevsky, Yama F. Mujadidi, Emma Plested, Maheshi N. Ramasamy, Peter Simmonds, Tanya Golubchik, Merryn Voysey, Andrew J. Pollard, the AMPHEUS Project, Oxford COVID Vaccine Trial Team
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-10 (2021)
Emerging variants of SARS-CoV-2 raise concerns about vaccine efficiency. Here, the authors present a post-hoc analysis for the ChAdOx1 nCoV-19 (AZD1222) vaccine trial in Brazil and provide efficacy against symptomatic COVID-19 caused by the Zeta (P.2
Externí odkaz:
https://doaj.org/article/2174b542d59f4531bfbfd908fa719572